Back to search

Article

Molecular Characterization of PARP Inhibitor Response Reveals Co-Targeting Strategies in Advanced Prostate Cancer

2026-06-16

Abstract excerpt

<h4>Background: </h4> /Objectives: Though PARP inhibition has improved the management of advanced prostate cancer, patient outcomes may be modest and progression on treatment is common. We sought to improve understanding of tumor cell response to PARP inhibition to support development of novel strategies to enhance and/or prolong PARP inhibitor (PARPi) efficacy. <h4>Methods:</h4> Cell viability assays and microsco...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3b8ac105-ec9e-560e-adfe-faf29cd2369a
DOI
10.20944/preprints202606.1162.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular Characterization of PARP Inhibitor Response Reveals Co-Targeting Strategies in Advanced Prostate CancerDOI 10.20944/preprints202606.1162.v1
Targeting PARP in Prostate Cancer: Novelty, Pitfalls, and Promise.Semantic proximity
Dual Roles of PARP-1 Promote Cancer Growth and ProgressionSemantic proximity
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate CancerSemantic proximity
PARP Inhibitors in Prostate Cancer.Semantic proximity
PARP Inhibitors in Prostate and Urothelial CancersSemantic proximity
Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate CancerSemantic proximity
PARP Inhibitors in Prostate Cancer–the Preclinical Rationale and Current Clinical DevelopmentSemantic proximity
PARP Inhibitors in the Treatment of Prostate Cancer: From Scientific Rationale to Clinical DevelopmentSemantic proximity
PARP Inhibition in Prostate Cancer With Homologous Recombination Repair AlterationsSemantic proximity
PARP inhibitors in advanced prostate cancer: when to use them?Semantic proximity
PARP inhibitors for prostate cancerSemantic proximity
Androgen receptor inhibition extends PARP inhibitor activity in prostate cancer models beyond BRCA mutations and defects in homologous recombination repairSemantic proximity
Select a neighboring publication to make it the new centre.